These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35216968)

  • 61. Radiologic-Histopathologic Correlation of Transvaginal US and Risk-reducing Salpingo-oophorectomy for Women at High Risk for Tubo-ovarian Carcinoma.
    Sakala MD; Curci NE; Masch WR; Mendiratta-Lala M; Stein EB; Wasnik AP; Sciallis AP; Uppal S; Pearlman MD; Maturen KE
    Radiol Imaging Cancer; 2020 Nov; 2(6):e190086. PubMed ID: 33778746
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.
    Hensley ML; Robson ME; Kauff ND; Korytowsky B; Castiel M; Ostroff J; Hurley K; Hann LE; Colon J; Spriggs D
    Gynecol Oncol; 2003 Jun; 89(3):440-6. PubMed ID: 12798709
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The association of hysterectomy with or without ovarian conservation with subclinical atherosclerosis progression in healthy postmenopausal women.
    Chen IJ; Shoupe D; Karim R; Stanczyk FZ; Kono N; Sriprasert I; Hodis HN; Mack WJ
    Menopause; 2023 Jul; 30(7):692-702. PubMed ID: 37192828
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
    Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).
    Manjer J; Johansson R; Berglund G; Janzon L; Kaaks R; Agren A; Lenner P
    Cancer Causes Control; 2003 Sep; 14(7):599-607. PubMed ID: 14575357
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does anti-Müllerian hormone predict change in menopausal symptoms following risk-reducing salpingo-oophorectomy? A prospective observational study.
    Vermeulen RFM; van Beurden M; Gaarenstroom KN; Teunis T; Kieffer JM; Aaronson NK; Kenter GG; Korse CM
    Climacteric; 2018 Dec; 21(6):574-580. PubMed ID: 30295077
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum sex hormones and breast cancer risk factors in postmenopausal women.
    Lamar CA; Dorgan JF; Longcope C; Stanczyk FZ; Falk RT; Stephenson HE
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):380-3. PubMed ID: 12692114
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Case-control study of endogenous steroid hormones and endometrial cancer.
    Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
    J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study.
    Grandi G; Sammarini M; Cortesi L; Toss A; Botticelli L; Varliero F; Sighinolfi G; Barbieri E; Facchinetti F
    Menopause; 2021 Feb; 28(3):263-270. PubMed ID: 33534430
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.
    Key T; Appleby P; Barnes I; Reeves G;
    J Natl Cancer Inst; 2002 Apr; 94(8):606-16. PubMed ID: 11959894
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ovarian surveillance including endometrial cytology for patients with hereditary breast and ovarian cancer before risk-reducing salpingo-oophorectomy: A retrospective analysis.
    Fusegi A; Nomura H; Ueki A; Abe A; Kamata M; Misaka S; Aoki Y; Tanigawa T; Yunokawa M; Kanao H
    J Obstet Gynaecol Res; 2024 Jun; 50(6):1002-1009. PubMed ID: 38528763
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
    Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
    [TBL] [Abstract][Full Text] [Related]  

  • 73. What happens after menopause? (WHAM): A prospective controlled study of sleep quality up to 12 months after premenopausal risk-reducing salpingo-oophorectomy.
    Hickey M; Moss KM; Krejany EO; Wrede CD; Domchek SM; Kirk J; Brand A; Trainer A; Mishra GD; Baker FC
    Gynecol Oncol; 2021 Aug; 162(2):447-453. PubMed ID: 34116835
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endogenous sex hormones, aromatase activity and lung cancer risk in postmenopausal never-smoking women.
    Zhao Y; Gao YT; Zhang X; Rockwood AL; Kushnir MM; Cai Q; Wu J; Shi J; Lan Q; Rothman N; Shyr Y; Shu XO; Zheng W; Yang G
    Int J Cancer; 2022 Sep; 151(5):699-707. PubMed ID: 35338778
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The hormonal activity of the postmenopausal ovary.
    Vermeulen A
    J Clin Endocrinol Metab; 1976 Feb; 42(2):247-53. PubMed ID: 177438
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sex hormone changes during weight loss and maintenance in overweight and obese postmenopausal African-American and non-African-American women.
    Stolzenberg-Solomon RZ; Falk RT; Stanczyk F; Hoover RN; Appel LJ; Ard JD; Batch BC; Coughlin J; Han X; Lien LF; Pinkston CM; Svetkey LP; Katki HA
    Breast Cancer Res; 2012 Oct; 14(5):R141. PubMed ID: 23113944
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hormone concentrations in the homogenates of ovarian tissue and blood serum in postmenopausal women not using hormone therapy.
    Brodowski J; Brodowska A; Laszczyńska M; Chlubek D; Starczewski A
    Gynecol Endocrinol; 2012 May; 28(5):396-9. PubMed ID: 22420607
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
    Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
    JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Coronary heart disease risk profile in women who underwent salpingo-oophorectomy to prevent hereditary breast ovarian cancer.
    Michelsen TM; Tonstad S; Pripp AH; Tropé CG; Dørum A
    Int J Gynecol Cancer; 2010 Feb; 20(2):233-9. PubMed ID: 20169665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.